Actively Recruiting
Timely Administration of IV Magnesium Sulfate in Patients With a Moderate Asthma Exacerbation
Led by University of Oklahoma · Updated on 2024-12-06
100
Participants Needed
1
Research Sites
78 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to identify whether early administration of magnesium sulfate in moderate asthma exacerbations can potentially avoid admission, decrease length of stay in the emergency department (ED), decrease length of stay (LOS) in the general hospital floor vs pediatric intensive care unit (PICU), and decrease the need for respiratory support.
CONDITIONS
Official Title
Timely Administration of IV Magnesium Sulfate in Patients With a Moderate Asthma Exacerbation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Ages 5 to 17 years old
- Presents to the emergency department with a respiratory score in the moderate range (6 to 9)
- Parent(s) or caregiver(s) speak English
You will not qualify if you...
- Presence of chronic medical conditions such as chronic pulmonary disease other than asthma, cerebral palsy, congenital heart disease, tracheostomy dependence, or myasthenia gravis
- Pregnancy
- Parent(s) or caregiver(s) do not speak English
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Oklahoma Children's Hospital
Oklahoma City, Oklahoma, United States, 73104
Actively Recruiting
Research Team
R
Ryan McKee, MD
CONTACT
J
Jaclyn Urquiola Sorzano, DO
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here